Identification of early biomarkers in a rabbit model of primary Candida pneumonia

Gang Lu1, Chen Wang2, Chunrong Wu1

  • 1Department of Trauma-Emergency & Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, No. 128 Ruili Road, Shanghai, 200240, China.

Abstract

Insights

Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and soluble hemoglobin-haptoglobin scavenger receptor (sCD163) show promise as biomarkers for diagnosing invasive Candida albicans pneumonia. These markers may help improve diagnostic accuracy and reduce unnecessary antifungal treatments.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Candida albicans is an opportunistic pathogen and part of normal fungal flora.
  • Positive sputum cultures alone can lead to over-treatment of invasive Candida albicans pneumonia.
  • Biomarker identification is crucial for improving diagnostic accuracy.

Purpose of the Study:

  • To evaluate potential biomarkers for diagnosing invasive Candida albicans pneumonia.
  • To assess the diagnostic utility of sTREM-1 and sCD163 in a rabbit model of pneumonia.

Main Methods:

  • A rabbit model of Candida albicans pneumonia was established.
  • Serum biomarker levels (sTREM-1, sCD163, PCT, TNF-α, CRP, IL-6, IL-8, IL-10) were measured using ELISA.
  • Chest CT scans, histopathology, and blood cultures were used for monitoring and diagnosis.

Main Results:

  • sTREM-1 and sCD163 levels were significantly elevated in infected rabbits compared to controls.
  • sTREM-1 demonstrated 85% sensitivity and 80% specificity (AUC 0.882).
  • sCD163 showed 80% sensitivity and 75% specificity (AUC 0.814).

Conclusions:

  • sTREM-1 and sCD163 are potential biomarkers for invasive Candida albicans pneumonia.
  • These biomarkers may aid in differentiating true infections from colonization.
  • Further validation in clinical settings is warranted.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
772
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
775
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
802
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
816